Characterisation of PD-L1-positive subsets of microsatellite-unstable colorectal cancers

被引：0
|
作者：
Jung Ho Kim
Hye Eun Park
Nam-Yun Cho
Hye Seung Lee
Gyeong Hoon Kang
机构：
[1] Seoul National University Hospital,Department of Pathology
[2] Seoul National University College of Medicine,Department of Pathology
[3] Laboratory of Epigenetics,undefined
[4] Cancer Research Institute,undefined
[5] Seoul National University College of Medicine,undefined
[6] Seoul National University Bundang Hospital,undefined
来源：
British Journal of Cancer | 2016年 / 115卷
关键词：
colorectal cancer; immune checkpoint; immunotherapy; microsatellite instability; mismatch repair; programmed death-1; programmed death ligand-1; tumour immunology;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：490 / 496
页数：6
相关论文
共 50 条
  • [31] High numbers of PDCD1 (PD-1)-positive T cells and B2M mutations in microsatellite-unstable colorectal cancer
    Janikovits, Jonas
    Mueller, Meike
    Krzykalla, Julia
    Koerner, Sandrina
    Echterdiek, Fabian
    Lahrmann, Bernd
    Grabe, Niels
    Schneider, Martin
    Benner, Axel
    Doeberitz, Magnus von Knebel
    Kloor, Matthias
    ONCOIMMUNOLOGY, 2018, 7 (02):
  • [32] Differential expression of DOC-1 in microsatellite-unstable human colorectal cancer
    Ziqiang Yuan
    Tara Sotsky Kent
    Thomas K Weber
    Oncogene, 2003, 22 : 6304 - 6310
  • [33] Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer
    Malesci, Alberto
    Laghi, Luigi
    Bianchi, Paolo
    Delconte, Gabriele
    Randolph, Ann
    Torri, Valter
    Carnaghi, Carlo
    Doci, Roberto
    Rosati, Riccardo
    Montorsi, Marco
    Roncalli, Massimo
    Gennari, Leandro
    Santoro, Armando
    CLINICAL CANCER RESEARCH, 2007, 13 (13) : 3831 - 3839
  • [34] Spectrum of druggable gene fusions in microsatellite-unstable colorectal tumors
    Imyanitov, E.
    Anuskina, A.
    Iyevleva, A. G.
    Mitiushkina, N. V.
    Mulkidzhan, R.
    Preobrazhenskaya, E.
    Romanko, A.
    Saitova, E.
    Tiurin, V.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S593 - S593
  • [35] Pembrolizumab effective in PD-L1-positive disease
    Stone L.
    Nature Reviews Urology, 2018, 15 (11) : 656 - 656
  • [36] Instabilotyping reveals unique mutational spectra in microsatellite-unstable gastric cancers
    Mori, Y
    Sato, F
    Selaru, FM
    Olaru, A
    Perry, K
    Kimos, MC
    Tamura, G
    Matsubara, N
    Wang, SN
    Xu, Y
    Yin, J
    Zou, TT
    Leggett, B
    Young, J
    Nukiwa, T
    Stine, OC
    Abraham, JM
    Shibata, D
    Meltzer, SJ
    CANCER RESEARCH, 2002, 62 (13) : 3641 - 3645
  • [37] Pembrolizumab for all PD-L1-positive NSCLC
    Smit, Egbert F.
    de langen, Adrianus J.
    LANCET, 2019, 393 (10183): : 1776 - 1778
  • [38] Benefit in patients with PD-L1-positive TNBC
    Diana Romero
    Nature Reviews Clinical Oncology, 2019, 16 : 6 - 6
  • [39] Benefit in patients with PD-L1-positive TNBC
    Romero, Diana
    NATURE REVIEWS CLINICAL ONCOLOGY, 2019, 16 (01) : 6 - 6
  • [40] Difference Between Proximal and Distal Microsatellite-Unstable Sporadic Colorectal Cancers: Analysis of Clinicopathological and Molecular Features and Prognoses
    Young-Ho Kim
    Byung-Hoon Min
    Sue Jin Kim
    Hyo Kyung Choi
    Kyoung-Mee Kim
    Ho-Kyung Chun
    Hyuk Lee
    Jin Yong Kim
    Dong Kyung Chang
    Hee Jung Son
    Poong-Lyul Rhee
    Jong Chul Rhee
    Jae J. Kim
    Annals of Surgical Oncology, 2010, 17 : 1435 - 1441
12345